-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Initiates Coverage On Beta Bionics with Outperform Rating, Announces Price Target of $20

Benzinga·05/30/2025 15:35:20
Listen to the news
Wolfe Research analyst Mike Polark initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Outperform rating and announces Price Target of $20.